Impact of Reclassification of Oncocytic and Follicular Thyroid Carcinoma by the 2022 WHO Classification. Stegenga MT, Oudijk L, van Velsen EFS, Peeters RP, et al. J Clin Endocrinol Metab 2024 Aug 21:dgae581. doi: 10.1210.

Read + Share

Amedeo Smart

Independent Medical Education

Stegenga MT, Oudijk L, van Velsen EFS, Peeters RP, et al. Impact of Reclassification of Oncocytic and Follicular Thyroid Carcinoma by the 2022 WHO Classification. J Clin Endocrinol Metab 2024 Aug 21:dgae581. doi: 10.1210.
PMID: 39166490